StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PASUPTAC.BO$69.26-3.09%
Fair $69.26+0.0%

PASUPTAC.BO

Pasupati Acrylon Limited

Consumer Cyclical / Textile ManufacturingBSE

$69.26

-1.91 (-3.09%)

Fairly Valued+0.0%Fair Value $69.26Fund rank 25/100 · Data gapFallback financials|
SA 67/B
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-226.9M · quality 43.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

67/100

B

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · PASUPTAC.BOLocal privado en este navegador · Pasupati Acrylon Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6.2B

P/E

8.8x

↓

EV/EBITDA

5.7x

↓

ROE

16.1%

↑

Gross Margin

29.8%

↑

Debt/Equity

0.25

↓
52-Week Range$69
$40$66

TradingView lightweight chart

PASUPTAC.BO price, volumen y niveles de valoración

Último $59.94Periodo +3532.7%
Fair value: $69.26

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+6.9%

FCF CAGR

+15.1%

FCF margin

3.5%

FCF / Net income

0.51x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.10B · net income $699.2M · FCF $354.5M

2023-FY → 2026-FY

Gross margin

29.8%+6.4% pts

Operating margin

9.8%+4.0% pts

Net margin

6.9%+2.6% pts

FCF margin

3.5%+0.7% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$10.10B$10.10B$6.21B$5.75B$8.26B
Net Income$699.2M$699.2M$353.8M$131.9M$359.1M
EBITDA$1.19B$1.19B$562.1M$268.5M$553.9M
EPS——3.971.484.03
Gross Margin29.8%29.8%26.6%20.4%23.4%
Operating Margin9.8%9.8%6.3%1.8%5.7%
Net Margin6.9%6.9%5.7%2.3%4.3%
Balance Sheet
Debt/Equity0.250.250.300.130.00
Current Ratio4.254.25———
Cash Flow
Free Cash Flow$354.5M$354.5M$-825.3M$-226.9M$232.4M
Returns
ROE16.1%16.1%9.7%4.0%11.4%
Valuation
P/E8.838.8312.8627.077.11
EV/EBITDA5.725.729.6313.664.25
P/B1.421.421.251.090.81
Growth & Yield
Revenue Growth62.6%62.6%8.0%-30.3%—
EPS Growth——168.2%-63.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +30.9%

Total return

+30.9%

Start / end P/E

n/dx → n/dx

EPS bridge

3.97 → n/d

Residual

+30.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+30.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.